Screening for Hepatitis B in partners and children of women positive for surface antigen, Burkina Faso

• Published in: Bulletin of the World Health Organization Vol. 100; no. 4; pp. 256 - 267
• Main Authors: Guingané, Alice Nanelin, Kaboré, Rémi, Shimakawa, Yusuke, Somé, Eric Nagaonlé, Kania, Dramane, Pisoni, Amandine, Nagot, Nicolas, King, Rachel, Sombié, Roger, Meda, Nicolas, Van de Perre, Philippe, Tuaillon, Edouard
• Format: Journal Article
• Language: English
• Published: Switzerland World Health Organization 01.04.2022
• Subjects: Antigens, Surface; Burkina Faso - epidemiology; Child; Female; Hepatitis B - diagnosis; Hepatitis B - epidemiology; Hepatitis B - prevention & control; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical - prevention & control; Life Sciences; Pregnancy; Pregnancy Complications, Infectious - prevention & control; Burkina Faso
• ISSN: 0042-9686; 1564-0604; 1564-0604
• DOI: 10.2471/BLT.21.287015

To evaluate the implementation of a screening strategy for the partners and children of pregnant women with hepatitis B virus (HBV) attending antenatal care. We identified pregnant women positive for HBV surface antigen (HBsAg) at antenatal consultation in Ouagadougou, Burkina Faso. At post-test counselling, women were advised to disclose their HBV status to partners and to encourage their partner and children to be screened for HBsAg. We used multivariable logistic regression to explore factors associated with uptake of screening and HBsAg positivity among family members. Of 1000 HBsAg-positive women, 436/1000 partners and 215/1281 children were screened. HBsAg was detected in 55 (12.6%) partners and 24 (11.2%) children. After adjusting for confounders, uptake of screening was higher in partners who were married, who attended the woman's first post-test consultation and to whom the woman had disclosed her HBV status. In children, HBsAg positivity was associated with being born before the introduction of infant hepatitis B vaccination in Burkina Faso (not significant in the multivariable analysis), having a mother positive for HBV e-antigen (adjusted OR: 8.57; 95% CI: 2.49-29.48) or having a mother with HBV DNA level ≥ 200 000 IU/mL (OR: 6.83; 95% CI: 1.61-29.00). In low-income countries, the antenatal consultation provides a cost-effective opportunity to identify HBV-infected household contacts and link them to care. Children born before the introduction of infant hepatitis B vaccination and whose mother has higher viral load or infectivity should be a priority for testing and linkage to care.